Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
651 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2018
652 Does Simple Oral Route of Administration Affect Acute Post Operative Pain?(Oral Pregabalin Versus Oral Morphine Sulphate) for Acute Post Operative Pain following Cancer Surgeries Department of Anesthesia, Intensive care and Pain management Dr. Alaa Ali Mohamed El-Zohry 2018
653 comparison between frequency ablation and chemical neurolysis of thoracic plainchant nerves for the management of abdominal cancer pain , randomized trial Department of Anesthesia, Intensive care and Pain management Prof. Samy Abdel Rahman Amr Erfan 2018
654 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2018
655 Effect of Dexmedetomidine Added to Modified Pectoral Block on Postoperative Pain and Stress
Response in Patient Undergoing Modified Radical Mastectomy 		Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2018
656 epidural dexmedetomidine infusion for
perioperative analgesia in patients undergoing
abdominal cancer surgery: randomized trial 		Department of Anesthesia, Intensive care and Pain management Dr. Diab Fuad Hetta 2018
657 Effect of Transcranial Direct Current Stimulation of the Motor Cortex on Visceral Pain in Patients with Hepatocellular Carcinoma. Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2018
658 Fibroblast growth factor-23 is independently associated with the left ventricular mass index in hemodialysis patients Department of Clinical Pathology Dr. Noha gaber sayed 2018
659 Clinicopathologic Characteristics of Colorectal Polyps: A Study from South Egypt Cancer Institute Department of Pathology Israa Mostafa Kamal Mohammed 2018
660 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2018